LexaGene (LXG) News Today C$0.10 -0.03 (-19.23%) (As of 02/21/2023) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Pamapol Ord Share Price (0LXG)April 9, 2024 | lse.co.ukBiosynex SA ALBIONovember 12, 2023 | morningstar.comCyclopharm Ltd CYCOctober 31, 2023 | morningstar.comLexagene Holdings Inc (LXGh)October 16, 2023 | investing.comEurobio Scientific Bearer and/or Registered shares issued from reverse spliSeptember 2, 2023 | morningstar.comZhejiang Gongdong Medical Technology Co Ltd Class AJuly 28, 2023 | morningstar.comIIROC Trading Halt - LXGFebruary 22, 2023 | finance.yahoo.comLexaGene Says Large Biopharma Co Engages It in Statement of Work to Expedite Technology Validation - Marketscreener.comOctober 20, 2022 | marketscreener.comLarge Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation - GlobeNewswireOctober 20, 2022 | globenewswire.comForm 10-Q LexaGene Holdings Inc. For: Aug 31 - StreetInsider.comOctober 19, 2022 | streetinsider.comLexaGene Rises 23% as Says Got Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.comOctober 13, 2022 | marketscreener.comLexaGene Says Received Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.comOctober 13, 2022 | marketscreener.comLexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System - GlobeNewswireOctober 13, 2022 | globenewswire.comVeterinary Infectious Disease Diagnostics Global Market Report 2022: Increasing Incidence of Transboundary and Zoonotic Diseases Drives Growth - ResearchAndMarkets.com - Business WireOctober 4, 2022 | businesswire.comLexaGene Announces MiQLab® System Sale to Veterinary Hospital in California - Financial PostSeptember 1, 2022 | financialpost.comLexaGene Announces MiQLab® Sys - GuruFocus.comSeptember 1, 2022 | gurufocus.comLEXAGENE HLDGS INC ORD by Lexagene Hldgs Inc. (LXXGF), (TSXV:LXG) – LexaGene Announces MiQLab® System Sal - BenzingaSeptember 1, 2022 | benzinga.comLexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared - GlobeNewswireAugust 29, 2022 | globenewswire.comLexaGene's MiQLab System Generates Leptospira Results in as - GlobeNewswireAugust 24, 2022 | globenewswire.comLexaGene : OTCQB Cert - Marketscreener.comAugust 23, 2022 | marketscreener.comLexaGene Says U of Penn's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel With MiQLab System - Marketscreener.comAugust 17, 2022 | marketscreener.comUniversity of Pennsylvania's School of Veterinary Medicine - GlobeNewswireAugust 17, 2022 | globenewswire.comLexaGene Reduces Time-to-Result by ~35% - GlobeNewswireAugust 10, 2022 | globenewswire.comForm 10-12G/A LexaGene Holdings Inc. - StreetInsider.comAugust 9, 2022 | streetinsider.comRising Transboundary And Zoonotic Disease Cases Are Fueling The Growth Of The Veterinary Infectious Disease Diagnostics Market As Per The Business Research Company's Veterinary Infectious Disease Diagnostics Global Market Report 2022 - Yahoo FinanceAugust 3, 2022 | finance.yahoo.comRising Transboundary And Zoonotic Disease Cases Are Fueling The Growth Of The Veterinary Infectious Disease Diagnostics Market As Per The Business Research Company's Veterinary Infectious Disease Diagnostics Global Market Report 2022 - GlobeNewswireAugust 3, 2022 | globenewswire.comLexaGene Announces Filing of Financial Statements, Revocation of MCTO & the Granting of Incentive Equity Awards to Employees - GlobeNewswireJuly 29, 2022 | globenewswire.comLexaGene Holdings Completes Multi-Center Validation Study Using MiQLab System for Diagnosing Urinary Tract Infections - Marketscreener.comJuly 27, 2022 | marketscreener.comGlobal COVID-19 Diagnostics Market Research Report 2022: Focus on PCR, PCR Multiplex, Sequencing, Antibody, & Antigens - Yahoo FinanceJuly 27, 2022 | finance.yahoo.comGlobal COVID-19 Diagnostics Market Research Report 2022: Focus on PCR, PCR Multiplex, Sequencing, Antibod - BenzingaJuly 27, 2022 | benzinga.comLexaGene Completes Multi-Center Validation Study Using MiQLab® System for Diagnosing Urinary Tract Infections - GlobeNewswireJuly 27, 2022 | globenewswire.comGlobal PCR Market Outlook Report 2022: The Instrumentation Curve, Shifting Role of Diagnostics, Diagnostics Moves Out of the Hospital, Disruption Looms, The Next Five Years - Yahoo FinanceJuly 23, 2022 | finance.yahoo.comLexaGene Provides MCTO Update - GlobeNewswireJuly 12, 2022 | globenewswire.comLexaGene Files Form 10 Registr - GuruFocus.comJuly 8, 2022 | gurufocus.comLexaGene Announces Webinar by UC Davis Professor on Use of MiQLab® System for Diagnosis of Urinary Tract Infections - GlobeNewswireJuly 5, 2022 | globenewswire.comUS benchmarks ride afternoon rally into 4th of July weekend - Proactive Investors USAJuly 1, 2022 | proactiveinvestors.comNA Proactive news snapshot: Naturally Splendid Enterprises, Aion Therapeutic, GoviEx Uranium, Kovo HealthTech ... - Proactive Investors CanadaJuly 1, 2022 | ca.proactiveinvestors.comNA Proactive news snapshot: Rio2 Limited, Nevada Copper, Naturally Splendid Enterprises, Aion Therapeutic, GoviEx Uranium UPDATE... - Proactive Investors USAJuly 1, 2022 | proactiveinvestors.comUS benchmarks start lower as traders await latest economic data - Proactive Investors USAJuly 1, 2022 | proactiveinvestors.comProactive news headlines including Kohl's, SpaceX, Hillcrest Energy Technologies, Naturally Splendid Enterprises and Aion Therapeutic - Financial PostJuly 1, 2022 | financialpost.comLexaGene Announces MiQLab® System Sale to Veterinary Hospital in Wisconsin - GuruFocus.comJuly 1, 2022 | gurufocus.comLexaGene Holdings announces MiQLab Systems sale to veterinary hospital in Wisconsin - Proactive Investors USAJuly 1, 2022 | proactiveinvestors.comLexaGene Announces Management Cease Trade Order - GuruFocus.comJune 30, 2022 | gurufocus.com2022-06-30 | TSXV:LXG | Press Release | Lexagene Holdings Inc - StockhouseJune 30, 2022 | stockhouse.comLexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings - Yahoo FinanceJune 29, 2022 | finance.yahoo.comLexaGene Holdings Reports Delay In Filing Year-End Financial Report - Marketscreener.comJune 29, 2022 | marketscreener.comLexaGene Files Form 10 Registration Statement with the SEC and Announces a Delay in Filing Year-End Annual Canadian Financial Filings - GlobeNewswireJune 28, 2022 | globenewswire.comLexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health - GuruFocus.comJune 24, 2022 | gurufocus.comNA Proactive news snapshot: Jushi Holdings, Evergen Infrastructure, Vox Royalty, Ready Set Gold ... - Proactive Investors USAMay 25, 2022 | proactiveinvestors.comLexaGene Announces Multi-System Purchase from a Large Market Leader in Animal Health - GlobeNewswireMay 25, 2022 | globenewswire.com Get LexaGene News Delivered to You Automatically Sign up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025. Click here to see the surprising reason why LXG Media Mentions By Week LXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LXG News Sentiment▼0.000.44▲Average Medical News Sentiment LXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LXG Articles This Week▼00▲LXG Articles Average Week Get LexaGene News Delivered to You Automatically Sign up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AKU News EDT News MBX News RHT News KDA News CWEB News ASG News LABS News ADK News NLH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:LXG) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LexaGene Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LexaGene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
